Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole on Nemiralisib PK in Healthy Subjects
NCT03398421Phase 1Completed
- Sponsor
- GSK
- Start
- Jan 2018
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nemiralisib in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Primary endpoints: Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinite Time, Area Under the Concentration-time Curve From Time Zero to Last Quantifiable Concentration and 3 more. Started Jan 2018; status: completed.
02
Drugs
nemiralisib
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03398421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03398421.